Combi-seq for multiplexed transcriptome-based profiling of drug combinations using deterministic barcoding in single-cell droplets.

Mathur L, Szalai B, Du NH, Utharala R, Ballinger M, Landry JJM, Ryckelynck M, Benes V, Saez-Rodriguez J, Merten CA

Nature communications, 2022

doi:10.1038/s41467-022-32197-0.

Combi-Seq: multiplexed transcriptome-based profiling of drug combinations using deterministic barcoding in single-cell droplets.

Mathur L, Szalai B, Utharala R, Ballinger M, Landry JJM, Ryckelynck M, Benes V, Saez-Rodriguez J, Merten CA

bioRxiv, 2021

doi:10.1101/2021.09.16.460212.

Microfluidics as an enabling technology for personalized cancer therapy.

Mathur L, Ballinger M, Utharala R, Merten CA

Small (Weinheim an der Bergstrasse, Germany), 2019

doi:10.1002/smll.201904321.